- Home
- / Genomic Vision
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Genomic Vision financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Total Funding
$2.4 M
Revenue
€1 M
FY, 2022
CreditSafe Score
?
Score changed on Jun 23, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| EUR | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 |
|---|---|---|---|---|---|
| Revenue | 1.1M | 1.8M | 1.1M | 994.0K | 1.0M |
| Cost of goods sold | 379.0K | 618.0K | 593.0K | 606.0K | 207.0K |
| Gross profit | 2.0M | 1.7M | 769.0K | 928.0K | 1.4M |
| Gross profit margin, % | 181.3% | 96.8% | 70.9% | 93.4% | 132.7% |
| Operating expense total | 8.4M | 5.9M | 5.2M | 5.4M | 7.1M |
| Depreciation and amortization | 537.0K | 872.0K | 988.0K | 442.0K | 351.0K |
| EBITDA | (6.4M) | (3.7M) | (4.2M) | (4.5M) | (5.8M) |
| EBITDA margin, % | -570.8% | -210.9% | -384.2% | -447.8% | -562.7% |
| EBIT | (6.9M) | (4.6M) | (5.2M) | (4.9M) | (6.1M) |
| EBIT margin, % | -619.7% | -260.2% | -475.4% | -492.3% | -596.9% |
| Interest income | 1.0K | ||||
| Interest expense | 3.0K | 2.0K | 31.0K | 72.0K | 682.0K |
| Pre tax profit | (6.9M) | (4.6M) | (5.2M) | (5.0M) | (6.8M) |
| Income tax expense | 37.0K | ||||
| Net Income | (6.9M) | (4.6M) | (5.2M) | (5.0M) | (6.8M) |